miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2

1 Brain and Neck Tumors Among Physicians Performing Interventional Procedures The American Journal of Cardiology, April 29, 2013

2 Enhancing drug delivery for boron neutron capture therapy of brain tumors with focused ultrasound Neuro-Oncology, May 7, 2013

3 Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677 Neuro-Oncology, May 6, 2013

4 Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastoma Cancer, May 1, 2013

5 Enhancing radiation therapy for patients with glioblastoma Expert Review of Anticancer Therapy, May 10, 2013

6 Celecoxib enhances radiosensitivity of hypoxic glioblastoma cells through endoplasmic reticulum stress Neuro-Oncology, May 10, 2013

7 Response Classification Based on a Minimal Model of Glioblastoma Growth Is Prognostic for Clinical Outcomes and Distinguishes Progression from Pseudoprogression Cancer Research, May 8, 2013

8 v-Integrin isoform expression in primary human tumors and brain metastases International Journal of Cancer, May 13, 2013

9 CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia Neuro-Oncology, May 6, 2013

10 New drug enhances radiation treatment for brain cancer in preclinical studies EurekAlert!, May 15, 2013